Cannabis consumers in the US span a broad spectrum of demographics, but almost all are looking for a way to switch off, finds a new report.
A new report examining the demographics of cannabis users in the US dispels some of the long-existing myths and stereotypes associated with the ‘typical’ cannabis consumers.
In February 2023, researchers at New Frontier Data surveyed over 5,500 people about their cannabis consumption.
The results show that while cannabis consumers span a diverse range of backgrounds, economic brackets and political standings, many are working professionals and almost all are looking for something to help them unwind.
According to the report, 42% of adults said they have used cannabis and will likely use it again, with 37% describing themselves as ‘current consumers’.
Of these, 37% said they had increased their consumption in the last year, with over a third using cannabis every couple of days. Despite over half living in a state where adult-use cannabis was legal, the authors say that frequency of use did not vary significantly by market type.
The demographic was split almost equally between men (54%) and women (46%), but the majority identified as white (63%) followed by Hispanic/Latinex (14%) and Black (14%).
Only 10% of those surveyed were ages 18- 24, with those aged 25-44 making up just under half (47%). Some18% were aged 45-54, 15% were 55-64 and 10% were over 65.
The majority of consumers were professionals, with most earning a salary between $25-75k and 38% having a bachelor’s degree or higher. Thirty eight percent also had children under the age of 18.
When asked about political alignment, 36% described themselves as ‘liberal’ and 26% ‘conservative’.
Reasons for consuming cannabis
The lines between medicinal and recreational use were blurred.
While most said they used ‘recreationally’, over half said their consumption was both medicinal and recreational, with chronic pain the most common indication and anxiety, depression and insomnia close behind.
Three quarters of self-identified ‘medical consumers’ were said to be treating a specific medical condition diagnosed by a doctor. Almost all (94%) said their condition had improved since consuming cannabis.
A significant proportion of non-consumers also said they would be open to trying cannabis if they became ill with a condition which may be helped by it.
How do people consume cannabis?
Joints were the most common form of consumption method, followed by edibles.
Even in states where adult-use cannabis was legal, there was limited access to a broad range of products. Fewer than half of consumers had access to products other than flowers, pre-rolls, and edibles.
THC potency and effect of the product were the attributes that consumers found most relevant when deciding which product to choose.
Of flower consumers, 77% said strain was important and 47% placed value on minor cannabinoid and terpene profiles.
Where are people sourcing their cannabis from?
While just under half (43%) are buying their cannabis from a brick-and-mortar dispensary, many are still sourcing it through friends and family members, with 15% having it delivered to them and 10% getting it from a dealer.
Only 2% of respondents said they grow their own cannabis at home.
Cannabis consumers need more options
While the report indicates a strong position and potential growth for the cannabis industry, the authors of the report say producers and regulators do more to meet the needs of consumers.
“The cannabis consumer demographic is diverse, with users spread across age groups, genders, economic brackets, and political affiliations,” the report states.
“A majority of cannabis consumers use the product for both medical and recreational purposes. This underscores the need for product development that focuses on delivering specific effects, such as boosting energy or relieving pain, and understanding that one consumer may seek several distinct effects in different contexts.”
The authors add: “Access to forms of cannabis other than flower and edibles remains limited for many consumers, even in adult-use states. As such, regulators should work to ensure that a wider variety of cannabis products are made available to consumers, and existing operators who have focused primarily on flower and edibles should expand their product offerings to reach new consumers, as well as providing existing consumers with additional product options.”
Want more stories like this delivered direct to your inbox? Sign up to our free weekly newsletter here
- Research shows ‘remarkable’ effects of cannabis in treatment of skin cancer
- Optimism despite delays: Ireland’s journey toward cannabis decriminalisation
- Medical Cannabis in the Management of Glaucoma
- President Zelensky signs bill legalising medical cannabis in Ukraine
- EU signals increasing shift in attitude towards cannabis reform
- Jersey passes ‘de jure’ decriminalisation of cannabis for personal use
News4 months ago
FSA drops recommended daily dose of CBD to 10mg – everything you need to know
Pain5 months ago
Medical cannabis ‘effective’ and ‘fast-acting’ for neuropathic pain – study
News4 months ago
UK government accepts ACMD recommendations for CBD products
Industry4 months ago
First UK-grown cannabis medicine expected by end of 2023
News5 months ago
The Netherlands to launch cannabis legalisation pilot December 2023
News5 months ago
BBC documentary highlights ‘pot luck’ of access to cannabis on NHS
Science5 months ago
New cannabis research: cancer, Type 2 diabetes, autism, fibromyalgia and skin disorders
News4 months ago
Europe’s first legal cannabis dispensaries to open under sixth Swiss pilot